Slingshot members are tracking this event:
Portola (PTLA) Expects CHMP Opinion in Q1 2018 for Andexxa (Andexanet Alfa) in Treatment of Serious Uncontrolled Bleeding Events
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 20, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Chmp, Andexxa, Andexanet Alfa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery